Virus Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Virus Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Herpes Zoster Virus Therapy
Reports from Mie University, Department of Dermatology advance knowledge in herpes zoster virus therapy
August 14th, 2007
New investigation results, "The change in zoster-associated pain treated with oral valaciclovir in immunocompetent patients with acute herpes zoster," are detailed in a study published in International Journal of Clinical Practice. "We have analysed zoster-associated pain treated with valaciclovir (VCV) in immunocompetent patients with acute herpes zoster over 6 months, and evaluated the safety of VCV. We know of no reports that evaluate postherpetic neuralgia (PHN) treated with VCV for 6 months," researchers in Tsu, Japan report. "Predisposing factors that influence PHN were age (over 60 years), clustered vesicles, severity of eruption, sleep disturbance, and...
Source: Virus Weekly (2007-08-14)
|